NCT01165138 - Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics | Biotech Hunter

Enrollment

612

Participants

Timeline

Start Date

August 20, 2010

Primary Completion Date

October 1, 2011

Study Completion Date

October 19, 2011

Conditions

Asthma

Interventions

DRUG

Fluticasone furoate/Vilanterol Inhalation Powder

Fluticasone furoate/Vilanterol Inhalation Powder inhaled orally once daily for 12 weeks

DRUG

Fluticasone Furoate Inhalation Powder

Fluticasone Furoate Inhalation Powder inhaled orally once daily for 12 weeks

DRUG

Placebo Inhaltion Powder

Placebo Inhaltion Powder inhaled orally once daily for 12 weeks

Trial Locations (70)

10787

GSK Investigational Site, Berlin

10789

GSK Investigational Site, Berlin

12165

GSK Investigational Site, Berlin

14057

GSK Investigational Site, Berlin

16515

GSK Investigational Site, Oranienburg

20354

GSK Investigational Site, Hamburg

21044

GSK Investigational Site, Columbia

29118

GSK Investigational Site, Orangeburg

33173

GSK Investigational Site, Miami

45231

GSK Investigational Site, Cincinnati

49006

GSK Investigational Site, Dnipropetrovsk

49051

GSK Investigational Site, Dnipropetrovsk

60305

GSK Investigational Site, River Forest

60596

GSK Investigational Site, Frankfurt am Main

61035

GSK Investigational Site, Kharkiv

61761

GSK Investigational Site, Normal

63571

GSK Investigational Site, Gelnhausen

65401

GSK Investigational Site, Rolla

68161

GSK Investigational Site, Mannheim

69076

GSK Investigational Site, Zaporizhia

73103

GSK Investigational Site, Oklahoma City

73112

GSK Investigational Site, Oklahoma City

73120

GSK Investigational Site, Oklahoma City

76018

GSK Investigational Site, Ivano-Frankivsk

77479

GSK Investigational Site, Sugar Land

78756

GSK Investigational Site, Austin

84107

GSK Investigational Site, Murray

90048

GSK Investigational Site, Los Angeles

90201

GSK Investigational Site, Bell Gardens

90808

GSK Investigational Site, Long Beach

92120

GSK Investigational Site, San Diego

92506

GSK Investigational Site, Riverside

92647

GSK Investigational Site, Huntington Beach

92663

GSK Investigational Site, Newport Beach

95043

GSK Investigational Site, Simferopol

95661

GSK Investigational Site, Roseville

97035

GSK Investigational Site, Lake Oswego

97213

GSK Investigational Site, Portland

97504

GSK Investigational Site, Medford

100550

GSK Investigational Site, Ploieşti

110084

GSK Investigational Site, Piteşti

200642

GSK Investigational Site, Craiova

300310

GSK Investigational Site, Timișoara

330084

GSK Investigational Site, Deva

400371

GSK Investigational Site, Cluj-Napoca

720284

GSK Investigational Site, Suceava

01307

GSK Investigational Site, Dresden

811-1394

GSK Investigational Site, Fukuoka

732-0052

GSK Investigational Site, Hiroshima

064-0801

GSK Investigational Site, Hokkaido

672-8048

GSK Investigational Site, Hyōgo

920-8530

GSK Investigational Site, Ishikawa

762-0031

GSK Investigational Site, Kagawa

252-0143

GSK Investigational Site, Kanagawa

603-8161

GSK Investigational Site, Kyoto

901-2132

GSK Investigational Site, Okinawa

158-0083

GSK Investigational Site, Tokyo

171-0014

GSK Investigational Site, Tokyo

194-0023

GSK Investigational Site, Tokyo

33-100

GSK Investigational Site, Tarnów

83-110

GSK Investigational Site, Tczew

53-301

GSK Investigational Site, Wroclaw

47-120

GSK Investigational Site, Zawadzkie

020674

GSK Investigational Site, Bucharest